Follow the 명문제약 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 명문제약 has recorded 77 insider filings. Market capitalisation: €43.8bn. The latest transaction was reported on 11 June 2026 (Other). Among the most active insiders: 우석민. The full history is openly available.
77
Insider Decl.
0
Thresholds
€11,558
57 ops.
Buy Volume
·
0 ops.
Sell Volume
12Σ signal
Buys €11,558· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 18,458 of 26,220 companies
38.1
score / 100
Value
40
Quality
37
FCF yld-21%
Earn yld4.6%
EV/EBITDA12.0x
ROE2.5%
Gross mgn55%
Net mgn1.0%
Debt/EBITDA8.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
